# Hyperthermic Intraperitoneal Treatment of rmhTNF for CRCPM: Phase II Clinical Trial

> **NCT05755685** · PHASE2 · UNKNOWN · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 10 (estimated)

## Conditions studied

- Peritoneal Metastases
- Colorectal Cancer

## Interventions

- **DRUG:** Hyperthermic intraperitoneal treatment of recombinant modified human tumor necrosis factor (rmhTNF)

## Key facts

- **NCT ID:** NCT05755685
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-10
- **Primary completion:** 2024-01-01
- **Final completion:** 2025-01-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2023-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05755685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05755685, "Hyperthermic Intraperitoneal Treatment of rmhTNF for CRCPM: Phase II Clinical Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05755685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*